MICHELLE MENKE: Open Payments
NPI 1659642858 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 56 payments from 15 companies in 2025. Trend: 2023 $1,310 · 2024 $899 · 2025 $1,010
Food & beverage: $1,010
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $256 |
| AstraZeneca Pharmaceuticals LP | 7 | $249 |
| Novo Nordisk Inc | 11 | $157 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Lilly USA, LLC | 3 | $50 |
| Sumitomo Pharma America, Inc. | 3 | $48 |
| Amgen Inc. | 3 | $44 |
| HARMONY BIOSCIENCES LLC | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Corium, LLC | 1 | $19 |
Products named: AIRSUPRA, VRAYLAR, Wegovy, QULIPTA, FARXIGA, Ozempic, UBRELVY, GEMTESA.
Industry payments across OH — which companies pay providers there.
